Goldman Sachs asks in biotech Report: Is curing patients a sustainable business? (2018)

The problem with investors these days is that too many of them seem so focused on short-term gains and showing their numbers increase quarter-over-quarter that we seem to be incapable of looking at an investment over a longer period of time.